| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 33 | 2024 | 2124 | 4.220 |
Why?
|
| Infant, Newborn | 145 | 2024 | 26395 | 3.700 |
Why?
|
| India | 66 | 2024 | 2323 | 3.170 |
Why?
|
| Sepsis | 16 | 2023 | 2602 | 3.130 |
Why?
|
| Enterocolitis, Necrotizing | 7 | 2023 | 327 | 3.070 |
Why?
|
| Retinopathy of Prematurity | 7 | 2023 | 449 | 2.750 |
Why?
|
| Infant, Premature, Diseases | 7 | 2023 | 712 | 2.540 |
Why?
|
| Oxytocics | 3 | 2023 | 67 | 2.170 |
Why?
|
| Anesthesia, Spinal | 4 | 2023 | 282 | 1.810 |
Why?
|
| Malnutrition | 5 | 2023 | 632 | 1.800 |
Why?
|
| Hypothermia, Induced | 3 | 2024 | 756 | 1.760 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 7 | 2023 | 239 | 1.680 |
Why?
|
| Rubella Syndrome, Congenital | 3 | 2021 | 12 | 1.610 |
Why?
|
| Neonatal Screening | 7 | 2022 | 618 | 1.600 |
Why?
|
| Phototherapy | 9 | 2019 | 369 | 1.600 |
Why?
|
| Intensive Care Units, Neonatal | 10 | 2023 | 861 | 1.570 |
Why?
|
| Resuscitation | 5 | 2023 | 680 | 1.450 |
Why?
|
| Rh Isoimmunization | 5 | 2024 | 23 | 1.340 |
Why?
|
| Iron Overload | 2 | 2023 | 241 | 1.310 |
Why?
|
| Infant Mortality | 7 | 2023 | 756 | 1.280 |
Why?
|
| Shock | 3 | 2022 | 316 | 1.280 |
Why?
|
| Anesthesia, Obstetrical | 4 | 2022 | 235 | 1.260 |
Why?
|
| Iodine Radioisotopes | 3 | 2022 | 1035 | 1.250 |
Why?
|
| Continuous Positive Airway Pressure | 4 | 2023 | 578 | 1.220 |
Why?
|
| Cesarean Section | 12 | 2023 | 1414 | 1.210 |
Why?
|
| Gestational Age | 19 | 2024 | 3615 | 1.210 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2023 | 592 | 1.200 |
Why?
|
| Pregnancy | 41 | 2023 | 30179 | 1.140 |
Why?
|
| Cervical Ripening | 3 | 2023 | 18 | 1.060 |
Why?
|
| Umbilical Cord | 3 | 2018 | 179 | 1.050 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2021 | 464 | 1.040 |
Why?
|
| Infant | 53 | 2024 | 36497 | 1.040 |
Why?
|
| Microtubule-Associated Proteins | 6 | 2017 | 1078 | 1.000 |
Why?
|
| Asphyxia Neonatorum | 3 | 2024 | 111 | 0.990 |
Why?
|
| Hyperbilirubinemia, Neonatal | 7 | 2015 | 30 | 0.960 |
Why?
|
| Blood Gas Analysis | 2 | 2024 | 384 | 0.950 |
Why?
|
| Colostrum | 3 | 2023 | 28 | 0.950 |
Why?
|
| Blindness | 3 | 2020 | 588 | 0.940 |
Why?
|
| Labor, Induced | 3 | 2023 | 152 | 0.940 |
Why?
|
| Microtubules | 9 | 2017 | 1074 | 0.930 |
Why?
|
| Enteral Nutrition | 6 | 2022 | 804 | 0.910 |
Why?
|
| Phenylephrine | 3 | 2023 | 294 | 0.890 |
Why?
|
| Humans | 224 | 2024 | 768451 | 0.880 |
Why?
|
| Blood Transfusion, Intrauterine | 2 | 2023 | 28 | 0.870 |
Why?
|
| Glucosephosphate Dehydrogenase | 3 | 2023 | 209 | 0.870 |
Why?
|
| HELLP Syndrome | 1 | 2023 | 41 | 0.870 |
Why?
|
| Ferritins | 2 | 2023 | 601 | 0.850 |
Why?
|
| Eisenmenger Complex | 1 | 2023 | 26 | 0.840 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2013 | 84 | 0.840 |
Why?
|
| Leukopenia | 1 | 2023 | 214 | 0.830 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2024 | 184 | 0.820 |
Why?
|
| Stillbirth | 2 | 2023 | 376 | 0.810 |
Why?
|
| Celiac Disease | 9 | 2021 | 819 | 0.790 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2019 | 80 | 0.760 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2022 | 329 | 0.760 |
Why?
|
| Amniotic Fluid | 1 | 2023 | 381 | 0.750 |
Why?
|
| Umbilical Arteries | 2 | 2018 | 77 | 0.740 |
Why?
|
| Masks | 1 | 2023 | 215 | 0.740 |
Why?
|
| Erythrocyte Transfusion | 5 | 2023 | 574 | 0.740 |
Why?
|
| Hypoxia-Ischemia, Brain | 3 | 2023 | 359 | 0.730 |
Why?
|
| Rubella | 1 | 2021 | 55 | 0.730 |
Why?
|
| Epilepsy | 5 | 2021 | 3324 | 0.730 |
Why?
|
| Female | 130 | 2024 | 396943 | 0.720 |
Why?
|
| Gamma Cameras | 1 | 2020 | 35 | 0.720 |
Why?
|
| Jaundice, Neonatal | 7 | 2016 | 71 | 0.720 |
Why?
|
| Myasthenic Syndromes, Congenital | 1 | 2020 | 17 | 0.710 |
Why?
|
| Premature Birth | 3 | 2023 | 1816 | 0.700 |
Why?
|
| Misoprostol | 1 | 2021 | 94 | 0.690 |
Why?
|
| Pupil Disorders | 1 | 2020 | 33 | 0.690 |
Why?
|
| Anticonvulsants | 5 | 2021 | 1923 | 0.690 |
Why?
|
| Shock, Septic | 4 | 2021 | 774 | 0.690 |
Why?
|
| Fetus | 2 | 2019 | 1883 | 0.690 |
Why?
|
| Hypothermia | 1 | 2021 | 188 | 0.680 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2023 | 477 | 0.680 |
Why?
|
| Pulmonary Surfactants | 4 | 2019 | 169 | 0.680 |
Why?
|
| Dinoprostone | 2 | 2021 | 597 | 0.670 |
Why?
|
| Delivery Rooms | 2 | 2023 | 38 | 0.660 |
Why?
|
| Hypoalbuminemia | 1 | 2020 | 90 | 0.650 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2022 | 2181 | 0.640 |
Why?
|
| Hernia, Umbilical | 1 | 2020 | 102 | 0.640 |
Why?
|
| Hepatitis B Vaccines | 2 | 2020 | 177 | 0.630 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2020 | 183 | 0.630 |
Why?
|
| Vasopressins | 1 | 2020 | 353 | 0.620 |
Why?
|
| Lactic Acid | 1 | 2023 | 1140 | 0.610 |
Why?
|
| Hydroxyprogesterones | 1 | 2018 | 24 | 0.610 |
Why?
|
| Failure to Thrive | 1 | 2019 | 140 | 0.600 |
Why?
|
| Urinary Catheterization | 1 | 2019 | 195 | 0.600 |
Why?
|
| Hypotension | 2 | 2022 | 888 | 0.600 |
Why?
|
| Tocolysis | 1 | 2017 | 18 | 0.590 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 2019 | 341 | 0.590 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2019 | 216 | 0.590 |
Why?
|
| Tocolytic Agents | 1 | 2017 | 24 | 0.580 |
Why?
|
| Neonatology | 4 | 2021 | 141 | 0.580 |
Why?
|
| Piracetam | 1 | 2018 | 88 | 0.570 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 2 | 2023 | 15 | 0.560 |
Why?
|
| Bilirubin | 9 | 2021 | 439 | 0.560 |
Why?
|
| Nifedipine | 1 | 2017 | 220 | 0.560 |
Why?
|
| Infectious Disease Transmission, Vertical | 8 | 2022 | 1359 | 0.560 |
Why?
|
| Vasoconstrictor Agents | 2 | 2022 | 658 | 0.560 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2019 | 182 | 0.550 |
Why?
|
| Caffeine | 1 | 2021 | 702 | 0.550 |
Why?
|
| Fetal Growth Retardation | 2 | 2018 | 585 | 0.550 |
Why?
|
| Acidosis | 2 | 2016 | 271 | 0.550 |
Why?
|
| Intestinal Obstruction | 2 | 2020 | 435 | 0.540 |
Why?
|
| Phenytoin | 1 | 2017 | 190 | 0.540 |
Why?
|
| Anthropometry | 3 | 2020 | 1343 | 0.540 |
Why?
|
| Fetal Distress | 1 | 2016 | 39 | 0.530 |
Why?
|
| Hepatitis B Antibodies | 2 | 2020 | 155 | 0.530 |
Why?
|
| Ephedrine | 1 | 2016 | 52 | 0.530 |
Why?
|
| Nephrotic Syndrome | 1 | 2020 | 382 | 0.530 |
Why?
|
| Prospective Studies | 29 | 2024 | 54914 | 0.530 |
Why?
|
| Quality Improvement | 4 | 2022 | 3858 | 0.530 |
Why?
|
| Oximetry | 2 | 2023 | 462 | 0.530 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2016 | 408 | 0.530 |
Why?
|
| Birth Weight | 9 | 2023 | 2117 | 0.520 |
Why?
|
| Meningitis, Bacterial | 2 | 2022 | 225 | 0.520 |
Why?
|
| Delivery, Obstetric | 1 | 2023 | 953 | 0.520 |
Why?
|
| Progestins | 1 | 2018 | 302 | 0.520 |
Why?
|
| Obstetric Labor, Premature | 1 | 2017 | 273 | 0.510 |
Why?
|
| Hematocrit | 1 | 2016 | 625 | 0.490 |
Why?
|
| Thrombocytopenia, Neonatal Alloimmune | 1 | 2015 | 19 | 0.490 |
Why?
|
| Exchange Transfusion, Whole Blood | 9 | 2015 | 59 | 0.490 |
Why?
|
| Typhoid Fever | 1 | 2016 | 195 | 0.480 |
Why?
|
| Celiac Artery | 1 | 2015 | 65 | 0.480 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2014 | 30 | 0.470 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2015 | 96 | 0.470 |
Why?
|
| Male | 98 | 2024 | 364781 | 0.470 |
Why?
|
| Anemia | 2 | 2023 | 1521 | 0.460 |
Why?
|
| Hepatitis B | 2 | 2020 | 707 | 0.460 |
Why?
|
| Blood Transfusion | 2 | 2018 | 1308 | 0.460 |
Why?
|
| Thyroid Hormones | 1 | 2017 | 407 | 0.450 |
Why?
|
| Sunlight | 1 | 2016 | 337 | 0.450 |
Why?
|
| Rheology | 1 | 2015 | 349 | 0.440 |
Why?
|
| Progesterone | 1 | 2018 | 750 | 0.440 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1257 | 0.440 |
Why?
|
| Milk, Human | 3 | 2023 | 489 | 0.430 |
Why?
|
| Prevalence | 10 | 2023 | 15880 | 0.420 |
Why?
|
| Erythroblastosis, Fetal | 3 | 2024 | 62 | 0.420 |
Why?
|
| Child | 41 | 2024 | 80863 | 0.410 |
Why?
|
| Body Surface Area | 1 | 2013 | 207 | 0.410 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2018 | 1767 | 0.410 |
Why?
|
| Child Development | 4 | 2021 | 2328 | 0.400 |
Why?
|
| Parents | 3 | 2023 | 3596 | 0.400 |
Why?
|
| Fatal Outcome | 5 | 2020 | 1840 | 0.400 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2017 | 414 | 0.390 |
Why?
|
| Diet, Gluten-Free | 5 | 2019 | 283 | 0.390 |
Why?
|
| Placenta | 2 | 2018 | 1724 | 0.390 |
Why?
|
| Rotavirus Infections | 3 | 2018 | 85 | 0.380 |
Why?
|
| Secondary Prevention | 1 | 2018 | 1479 | 0.380 |
Why?
|
| Oxygen | 7 | 2023 | 4269 | 0.380 |
Why?
|
| Pandemics | 4 | 2021 | 8753 | 0.380 |
Why?
|
| Rotavirus | 3 | 2018 | 110 | 0.380 |
Why?
|
| Body Height | 2 | 2018 | 1568 | 0.370 |
Why?
|
| Infection Control | 1 | 2018 | 985 | 0.370 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2011 | 41 | 0.370 |
Why?
|
| Klebsiella Infections | 3 | 2014 | 145 | 0.370 |
Why?
|
| Morbidity | 2 | 2013 | 1760 | 0.370 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2011 | 43 | 0.370 |
Why?
|
| Mortality | 2 | 2022 | 2917 | 0.370 |
Why?
|
| Perinatal Care | 3 | 2020 | 245 | 0.360 |
Why?
|
| Cystic Fibrosis | 1 | 2020 | 1287 | 0.360 |
Why?
|
| Health Personnel | 3 | 2020 | 3384 | 0.360 |
Why?
|
| Body Weight | 3 | 2020 | 4630 | 0.360 |
Why?
|
| Thyroid Neoplasms | 2 | 2022 | 2360 | 0.350 |
Why?
|
| Klebsiella pneumoniae | 2 | 2009 | 252 | 0.350 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2015 | 672 | 0.350 |
Why?
|
| Liver Abscess | 1 | 2010 | 81 | 0.350 |
Why?
|
| Cross Infection | 2 | 2018 | 1425 | 0.340 |
Why?
|
| Fluid Therapy | 6 | 2021 | 585 | 0.340 |
Why?
|
| Phenobarbital | 4 | 2021 | 192 | 0.340 |
Why?
|
| Physician's Role | 1 | 2016 | 927 | 0.340 |
Why?
|
| Norepinephrine | 2 | 2023 | 900 | 0.330 |
Why?
|
| Administration, Intravaginal | 2 | 2021 | 149 | 0.330 |
Why?
|
| Anemia, Aplastic | 1 | 2011 | 231 | 0.330 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3854 | 0.320 |
Why?
|
| Intensive Care, Neonatal | 2 | 2012 | 200 | 0.320 |
Why?
|
| Hyperparathyroidism, Primary | 2 | 2023 | 164 | 0.310 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 1605 | 0.310 |
Why?
|
| Infant Nutrition Disorders | 1 | 2009 | 70 | 0.310 |
Why?
|
| Brain Abscess | 1 | 2009 | 123 | 0.300 |
Why?
|
| Referral and Consultation | 1 | 2021 | 3629 | 0.300 |
Why?
|
| Patient Discharge | 1 | 2021 | 3471 | 0.300 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2239 | 0.300 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 4713 | 0.300 |
Why?
|
| Injections, Intramuscular | 2 | 2020 | 557 | 0.290 |
Why?
|
| Apgar Score | 3 | 2017 | 126 | 0.290 |
Why?
|
| Monitoring, Physiologic | 3 | 2014 | 1795 | 0.280 |
Why?
|
| Health Education | 2 | 2016 | 1059 | 0.280 |
Why?
|
| Kernicterus | 2 | 2021 | 11 | 0.280 |
Why?
|
| Pregnancy Complications | 2 | 2018 | 2969 | 0.270 |
Why?
|
| Child, Preschool | 27 | 2024 | 42623 | 0.270 |
Why?
|
| Genitalia, Male | 2 | 2024 | 87 | 0.270 |
Why?
|
| Cohort Studies | 14 | 2024 | 41797 | 0.270 |
Why?
|
| Treatment Outcome | 26 | 2021 | 65409 | 0.270 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1408 | 0.260 |
Why?
|
| Cyclotrons | 2 | 2017 | 30 | 0.260 |
Why?
|
| Cross-Sectional Studies | 12 | 2024 | 26351 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3116 | 0.260 |
Why?
|
| Head | 1 | 2011 | 927 | 0.260 |
Why?
|
| Mothers | 4 | 2023 | 2210 | 0.250 |
Why?
|
| Intestines | 1 | 2015 | 1912 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3240 | 0.250 |
Why?
|
| Viral Envelope Proteins | 1 | 2009 | 641 | 0.250 |
Why?
|
| Pregnancy Outcome | 3 | 2023 | 2959 | 0.250 |
Why?
|
| Spina Bifida Occulta | 1 | 2005 | 31 | 0.250 |
Why?
|
| Intestine, Small | 1 | 2011 | 1218 | 0.250 |
Why?
|
| Enuresis | 1 | 2005 | 50 | 0.250 |
Why?
|
| Dexamethasone | 1 | 2013 | 1965 | 0.250 |
Why?
|
| Physicians | 1 | 2023 | 4615 | 0.240 |
Why?
|
| Retrospective Studies | 22 | 2024 | 81834 | 0.240 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 1377 | 0.240 |
Why?
|
| Cytomegalovirus | 1 | 2009 | 755 | 0.240 |
Why?
|
| Incidence | 12 | 2023 | 21552 | 0.240 |
Why?
|
| Amino Acid Motifs | 3 | 2012 | 930 | 0.230 |
Why?
|
| Antifungal Agents | 2 | 2020 | 761 | 0.230 |
Why?
|
| Positive-Pressure Respiration | 3 | 2023 | 713 | 0.230 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2024 | 41 | 0.230 |
Why?
|
| Candidemia | 2 | 2014 | 39 | 0.230 |
Why?
|
| Parathyroid Neoplasms | 2 | 2023 | 244 | 0.230 |
Why?
|
| Gastric Lavage | 1 | 2023 | 17 | 0.230 |
Why?
|
| Hemodynamics | 4 | 2016 | 4202 | 0.220 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1183 | 0.220 |
Why?
|
| Meconium | 1 | 2023 | 47 | 0.220 |
Why?
|
| Combined Modality Therapy | 5 | 2019 | 8559 | 0.220 |
Why?
|
| Disorders of Sex Development | 1 | 2024 | 129 | 0.220 |
Why?
|
| Meningitis | 2 | 2022 | 219 | 0.210 |
Why?
|
| Biomedical Engineering | 1 | 2024 | 286 | 0.210 |
Why?
|
| Plethysmography | 1 | 2023 | 174 | 0.210 |
Why?
|
| Conjunctivitis | 2 | 2022 | 156 | 0.210 |
Why?
|
| Developing Countries | 4 | 2024 | 2901 | 0.210 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5510 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 1 | 2009 | 839 | 0.210 |
Why?
|
| Fluorine Radioisotopes | 3 | 2017 | 425 | 0.200 |
Why?
|
| Conjunctivitis, Inclusion | 1 | 2022 | 3 | 0.200 |
Why?
|
| HIV Infections | 5 | 2019 | 17564 | 0.200 |
Why?
|
| Young Adult | 12 | 2023 | 60045 | 0.200 |
Why?
|
| Genitalia, Female | 1 | 2023 | 146 | 0.200 |
Why?
|
| Amino Acids | 2 | 2022 | 1714 | 0.200 |
Why?
|
| Spinal Puncture | 1 | 2024 | 286 | 0.200 |
Why?
|
| Double-Blind Method | 6 | 2022 | 12450 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2023 | 10358 | 0.200 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3103 | 0.200 |
Why?
|
| Time Factors | 11 | 2018 | 40271 | 0.200 |
Why?
|
| ROC Curve | 2 | 2020 | 3624 | 0.200 |
Why?
|
| Vitamin D Deficiency | 2 | 2021 | 1389 | 0.200 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2022 | 105 | 0.200 |
Why?
|
| Rotation | 1 | 2023 | 517 | 0.200 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2017 | 2048 | 0.190 |
Why?
|
| Adenovirus Infections, Human | 1 | 2022 | 76 | 0.190 |
Why?
|
| Apnea | 2 | 2021 | 195 | 0.190 |
Why?
|
| Rickets | 1 | 2021 | 70 | 0.190 |
Why?
|
| Sodium Chloride | 2 | 2015 | 585 | 0.190 |
Why?
|
| Risk Factors | 15 | 2023 | 74915 | 0.190 |
Why?
|
| Constriction | 2 | 2018 | 168 | 0.190 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 544 | 0.190 |
Why?
|
| Keratin-7 | 1 | 2021 | 55 | 0.190 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2019 | 417 | 0.180 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2020 | 10 | 0.180 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 3 | 2010 | 95 | 0.180 |
Why?
|
| Skinfold Thickness | 1 | 2021 | 163 | 0.180 |
Why?
|
| Choline | 2 | 2023 | 518 | 0.180 |
Why?
|
| Administration, Oral | 3 | 2017 | 4041 | 0.180 |
Why?
|
| Hyponatremia | 2 | 2015 | 281 | 0.180 |
Why?
|
| Tablets | 1 | 2021 | 149 | 0.180 |
Why?
|
| Glucosylceramides | 1 | 2020 | 27 | 0.180 |
Why?
|
| Stroke | 1 | 2023 | 9791 | 0.180 |
Why?
|
| Health Promotion | 2 | 2011 | 2215 | 0.180 |
Why?
|
| Biliary Atresia | 1 | 2021 | 88 | 0.180 |
Why?
|
| Amphotericin B | 1 | 2020 | 143 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2009 | 2508 | 0.170 |
Why?
|
| Early Diagnosis | 3 | 2020 | 1196 | 0.170 |
Why?
|
| Child Health Services | 2 | 2019 | 645 | 0.170 |
Why?
|
| Fluconazole | 1 | 2020 | 156 | 0.170 |
Why?
|
| Rehabilitation Centers | 1 | 2021 | 250 | 0.170 |
Why?
|
| Hyperbilirubinemia | 2 | 2011 | 74 | 0.170 |
Why?
|
| Nose | 1 | 2023 | 524 | 0.170 |
Why?
|
| Whooping Cough | 1 | 2020 | 86 | 0.170 |
Why?
|
| Bronchi | 1 | 2024 | 847 | 0.170 |
Why?
|
| Mycobacterium leprae | 1 | 2019 | 95 | 0.170 |
Why?
|
| Hyperthyroidism | 2 | 2012 | 295 | 0.170 |
Why?
|
| Candida | 1 | 2020 | 172 | 0.170 |
Why?
|
| Parturition | 1 | 2023 | 453 | 0.160 |
Why?
|
| Adult | 24 | 2023 | 223542 | 0.160 |
Why?
|
| Mitosis | 2 | 2017 | 1191 | 0.160 |
Why?
|
| Hospital Costs | 1 | 2005 | 959 | 0.160 |
Why?
|
| Radionuclide Imaging | 3 | 2020 | 1998 | 0.160 |
Why?
|
| Leprosy | 1 | 2019 | 126 | 0.160 |
Why?
|
| Zygomycosis | 1 | 2018 | 7 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 7 | 2022 | 7471 | 0.160 |
Why?
|
| Oxytocin | 1 | 2023 | 402 | 0.160 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2019 | 62 | 0.160 |
Why?
|
| Seizures | 4 | 2021 | 2996 | 0.160 |
Why?
|
| Hepatitis | 1 | 2021 | 228 | 0.160 |
Why?
|
| Epithelial Cells | 3 | 2012 | 3697 | 0.160 |
Why?
|
| Clinical Audit | 1 | 2018 | 29 | 0.160 |
Why?
|
| Prenatal Care | 2 | 2023 | 1159 | 0.160 |
Why?
|
| Rural Population | 2 | 2009 | 2317 | 0.160 |
Why?
|
| Thigh | 1 | 2020 | 239 | 0.160 |
Why?
|
| Ultrasonography | 2 | 2024 | 5995 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2022 | 1197 | 0.160 |
Why?
|
| Hospitals | 2 | 2023 | 3906 | 0.160 |
Why?
|
| Ligation | 1 | 2019 | 447 | 0.160 |
Why?
|
| Antibodies, Viral | 2 | 2021 | 3212 | 0.160 |
Why?
|
| Lactation | 1 | 2021 | 397 | 0.150 |
Why?
|
| Hypotonic Solutions | 2 | 2015 | 48 | 0.150 |
Why?
|
| Breast Feeding | 3 | 2013 | 1365 | 0.150 |
Why?
|
| Catheters | 1 | 2021 | 427 | 0.150 |
Why?
|
| Regression Analysis | 2 | 2018 | 6353 | 0.150 |
Why?
|
| Child Mortality | 1 | 2020 | 204 | 0.150 |
Why?
|
| Cell Movement | 2 | 2010 | 5223 | 0.150 |
Why?
|
| Trachea | 1 | 2024 | 1095 | 0.150 |
Why?
|
| Pilot Projects | 3 | 2022 | 8730 | 0.150 |
Why?
|
| Isotonic Solutions | 2 | 2015 | 120 | 0.150 |
Why?
|
| Jaundice | 2 | 2016 | 95 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2023 | 1532 | 0.140 |
Why?
|
| Glucose | 2 | 2024 | 4355 | 0.140 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 275 | 0.140 |
Why?
|
| Genotype | 5 | 2018 | 13047 | 0.140 |
Why?
|
| Statistics, Nonparametric | 4 | 2013 | 2863 | 0.140 |
Why?
|
| Fast Foods | 1 | 2019 | 216 | 0.140 |
Why?
|
| Radiometry | 1 | 2022 | 816 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2018 | 182 | 0.140 |
Why?
|
| Needles | 1 | 2020 | 455 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 2096 | 0.140 |
Why?
|
| Leukocyte Count | 1 | 2021 | 1604 | 0.140 |
Why?
|
| Thyroidectomy | 1 | 2022 | 915 | 0.140 |
Why?
|
| Infant Care | 2 | 2021 | 182 | 0.140 |
Why?
|
| Chi-Square Distribution | 4 | 2013 | 3438 | 0.130 |
Why?
|
| Papilledema | 1 | 2018 | 130 | 0.130 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 527 | 0.130 |
Why?
|
| Pseudotumor Cerebri | 1 | 2018 | 107 | 0.130 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 119 | 0.130 |
Why?
|
| Diastole | 1 | 2018 | 784 | 0.130 |
Why?
|
| Respiratory Sounds | 2 | 2010 | 702 | 0.130 |
Why?
|
| Bacteremia | 3 | 2015 | 985 | 0.130 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2021 | 1064 | 0.130 |
Why?
|
| Delivery of Health Care | 3 | 2024 | 5367 | 0.130 |
Why?
|
| Vision, Low | 1 | 2018 | 163 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 3619 | 0.130 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 4567 | 0.130 |
Why?
|
| RNA, Viral | 2 | 2021 | 2865 | 0.130 |
Why?
|
| Kinetochores | 1 | 2017 | 180 | 0.130 |
Why?
|
| Radiotherapy Dosage | 1 | 2022 | 2925 | 0.130 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 462 | 0.130 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 325 | 0.130 |
Why?
|
| Drug Resistance, Multiple | 1 | 2016 | 255 | 0.120 |
Why?
|
| Respiration, Artificial | 3 | 2016 | 2723 | 0.120 |
Why?
|
| Case-Control Studies | 7 | 2023 | 22293 | 0.120 |
Why?
|
| Nutritional Status | 2 | 2021 | 1623 | 0.120 |
Why?
|
| Linear Models | 2 | 2024 | 5880 | 0.120 |
Why?
|
| Muscles | 1 | 2020 | 1582 | 0.120 |
Why?
|
| Cervix Uteri | 1 | 2019 | 577 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 562 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2016 | 2488 | 0.120 |
Why?
|
| Malassezia | 1 | 2014 | 8 | 0.120 |
Why?
|
| Patient Compliance | 2 | 2019 | 2696 | 0.120 |
Why?
|
| Neutrophils | 2 | 2019 | 3790 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 1965 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6537 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2358 | 0.120 |
Why?
|
| Staphylococcal Infections | 2 | 2021 | 1412 | 0.120 |
Why?
|
| Diagnosis, Differential | 6 | 2021 | 13026 | 0.120 |
Why?
|
| Placenta Accreta | 1 | 2018 | 241 | 0.120 |
Why?
|
| Cattle | 2 | 2019 | 3830 | 0.120 |
Why?
|
| HeLa Cells | 2 | 2012 | 3090 | 0.120 |
Why?
|
| Rivers | 1 | 2014 | 67 | 0.120 |
Why?
|
| Dermatomycoses | 1 | 2014 | 48 | 0.120 |
Why?
|
| Bradycardia | 1 | 2016 | 305 | 0.110 |
Why?
|
| Adolescent | 19 | 2023 | 89168 | 0.110 |
Why?
|
| Diet Therapy | 1 | 2015 | 151 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 643 | 0.110 |
Why?
|
| Sodium Fluoride | 1 | 2014 | 67 | 0.110 |
Why?
|
| Liver | 2 | 2021 | 7575 | 0.110 |
Why?
|
| Fatigue | 1 | 2021 | 1556 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 4 | 2021 | 875 | 0.110 |
Why?
|
| Radiopharmaceuticals | 5 | 2017 | 2731 | 0.110 |
Why?
|
| Aminoquinolines | 1 | 2014 | 105 | 0.110 |
Why?
|
| Gram-Positive Bacteria | 1 | 2015 | 180 | 0.110 |
Why?
|
| Skin | 2 | 2020 | 4520 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 3790 | 0.110 |
Why?
|
| Optic Disk | 1 | 2018 | 422 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2019 | 923 | 0.110 |
Why?
|
| Disease Progression | 3 | 2020 | 13655 | 0.110 |
Why?
|
| Metals, Heavy | 1 | 2014 | 149 | 0.110 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2013 | 17 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 2238 | 0.110 |
Why?
|
| Diarrhea | 2 | 2017 | 1320 | 0.110 |
Why?
|
| Echocardiography | 4 | 2021 | 5043 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2019 | 798 | 0.110 |
Why?
|
| Hysterectomy | 1 | 2018 | 863 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2015 | 276 | 0.100 |
Why?
|
| Heart Rate | 2 | 2023 | 4218 | 0.100 |
Why?
|
| Growth Disorders | 1 | 2018 | 635 | 0.100 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 1320 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 2 | 2010 | 833 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 387 | 0.100 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2013 | 136 | 0.100 |
Why?
|
| Albumins | 1 | 2015 | 578 | 0.100 |
Why?
|
| Malaria, Falciparum | 2 | 2011 | 1079 | 0.100 |
Why?
|
| Off-Label Use | 1 | 2014 | 186 | 0.100 |
Why?
|
| Immunoglobulin A | 1 | 2016 | 990 | 0.100 |
Why?
|
| Carbamates | 1 | 2014 | 192 | 0.100 |
Why?
|
| Keratinocytes | 1 | 2017 | 879 | 0.100 |
Why?
|
| Goiter | 1 | 2012 | 87 | 0.100 |
Why?
|
| Reference Values | 3 | 2024 | 4941 | 0.100 |
Why?
|
| Lung | 1 | 2011 | 10090 | 0.100 |
Why?
|
| Positron-Emission Tomography | 5 | 2017 | 6657 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2023 | 3115 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4861 | 0.100 |
Why?
|
| Mathematics | 1 | 2013 | 704 | 0.100 |
Why?
|
| Transglutaminases | 3 | 2019 | 200 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2017 | 8332 | 0.100 |
Why?
|
| Drug Monitoring | 2 | 2015 | 964 | 0.100 |
Why?
|
| Tremor | 1 | 2013 | 193 | 0.100 |
Why?
|
| Pediatrics | 3 | 2021 | 3622 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2018 | 1192 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2017 | 630 | 0.100 |
Why?
|
| Phantoms, Imaging | 1 | 2020 | 2528 | 0.100 |
Why?
|
| Follow-Up Studies | 9 | 2024 | 39430 | 0.100 |
Why?
|
| Static Electricity | 1 | 2012 | 261 | 0.090 |
Why?
|
| Growth Charts | 1 | 2011 | 60 | 0.090 |
Why?
|
| Vaccines | 1 | 2020 | 845 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 1502 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2013 | 4049 | 0.090 |
Why?
|
| Hospitalization | 5 | 2022 | 10845 | 0.090 |
Why?
|
| Term Birth | 1 | 2011 | 140 | 0.090 |
Why?
|
| Anemia, Megaloblastic | 1 | 2010 | 24 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 397 | 0.090 |
Why?
|
| Graves Disease | 1 | 2012 | 239 | 0.090 |
Why?
|
| Antibodies | 1 | 2019 | 2425 | 0.090 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2012 | 564 | 0.090 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 952 | 0.090 |
Why?
|
| Cause of Death | 2 | 2019 | 3727 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2015 | 473 | 0.090 |
Why?
|
| Vaccination | 2 | 2020 | 3434 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1557 | 0.090 |
Why?
|
| Sexual Maturation | 1 | 2012 | 261 | 0.090 |
Why?
|
| Trypanosoma cruzi | 1 | 2012 | 207 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 463 | 0.090 |
Why?
|
| Water Pollutants, Chemical | 1 | 2014 | 363 | 0.090 |
Why?
|
| Diclofenac | 1 | 2010 | 69 | 0.090 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 749 | 0.090 |
Why?
|
| Gemfibrozil | 1 | 2009 | 30 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 1543 | 0.090 |
Why?
|
| Cephalometry | 1 | 2011 | 379 | 0.090 |
Why?
|
| Biological Products | 1 | 2019 | 937 | 0.090 |
Why?
|
| Family | 1 | 2021 | 3208 | 0.090 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2011 | 244 | 0.090 |
Why?
|
| Turner Syndrome | 1 | 2011 | 130 | 0.080 |
Why?
|
| Primary Myelofibrosis | 1 | 2012 | 209 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2024 | 6429 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1424 | 0.080 |
Why?
|
| Pancytopenia | 1 | 2010 | 102 | 0.080 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2010 | 64 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 16029 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6242 | 0.080 |
Why?
|
| Malaria, Vivax | 1 | 2011 | 166 | 0.080 |
Why?
|
| Papaverine | 1 | 2009 | 45 | 0.080 |
Why?
|
| Emergencies | 1 | 2016 | 1222 | 0.080 |
Why?
|
| beta-Thalassemia | 1 | 2012 | 236 | 0.080 |
Why?
|
| Enterobacter aerogenes | 1 | 2009 | 2 | 0.080 |
Why?
|
| Bottle Feeding | 1 | 2009 | 67 | 0.080 |
Why?
|
| Neonatal Nursing | 1 | 2009 | 22 | 0.080 |
Why?
|
| Prognosis | 6 | 2024 | 30028 | 0.080 |
Why?
|
| Microtubule Proteins | 1 | 2009 | 63 | 0.080 |
Why?
|
| Hysteroscopy | 1 | 2009 | 62 | 0.080 |
Why?
|
| Blood Group Incompatibility | 1 | 2010 | 135 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2015 | 10125 | 0.080 |
Why?
|
| Iron | 1 | 2017 | 1813 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 434 | 0.080 |
Why?
|
| Platelet Count | 1 | 2011 | 786 | 0.080 |
Why?
|
| Focal Adhesions | 1 | 2009 | 114 | 0.080 |
Why?
|
| Glucuronosyltransferase | 1 | 2009 | 136 | 0.080 |
Why?
|
| Anesthesia, Intravenous | 1 | 2009 | 130 | 0.080 |
Why?
|
| Cell Physiological Phenomena | 1 | 2010 | 150 | 0.080 |
Why?
|
| Shock, Cardiogenic | 1 | 2014 | 711 | 0.080 |
Why?
|
| Hospitals, Teaching | 2 | 2020 | 1158 | 0.080 |
Why?
|
| Endocytosis | 1 | 2012 | 960 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 1 | 2009 | 326 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 1794 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2020 | 3335 | 0.070 |
Why?
|
| National Health Programs | 1 | 2011 | 442 | 0.070 |
Why?
|
| Visual Acuity | 1 | 2018 | 2714 | 0.070 |
Why?
|
| Oxidants | 1 | 2008 | 169 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 201 | 0.070 |
Why?
|
| Eukaryotic Cells | 1 | 2009 | 192 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2018 | 2601 | 0.070 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 998 | 0.070 |
Why?
|
| Severity of Illness Index | 6 | 2015 | 15965 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2023 | 8538 | 0.070 |
Why?
|
| Lidocaine | 1 | 2010 | 545 | 0.070 |
Why?
|
| Streptococcus agalactiae | 1 | 2009 | 338 | 0.070 |
Why?
|
| Acute Disease | 3 | 2013 | 7246 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2015 | 1397 | 0.070 |
Why?
|
| Anesthetics | 1 | 2013 | 525 | 0.070 |
Why?
|
| Free Radicals | 2 | 2005 | 238 | 0.070 |
Why?
|
| Autopsy | 1 | 2011 | 1013 | 0.070 |
Why?
|
| Health Facilities | 2 | 2022 | 576 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3586 | 0.070 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2009 | 238 | 0.070 |
Why?
|
| tau Proteins | 1 | 2017 | 2129 | 0.070 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2009 | 352 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2019 | 3063 | 0.070 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14728 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2010 | 682 | 0.060 |
Why?
|
| Nitrogen Radioisotopes | 2 | 2017 | 44 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2009 | 639 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2013 | 1185 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1600 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2011 | 792 | 0.060 |
Why?
|
| Recurrence | 1 | 2018 | 8510 | 0.060 |
Why?
|
| Models, Econometric | 1 | 2005 | 215 | 0.060 |
Why?
|
| Forecasting | 1 | 2014 | 2950 | 0.060 |
Why?
|
| Skull | 1 | 2009 | 832 | 0.060 |
Why?
|
| Protein Multimerization | 1 | 2010 | 980 | 0.060 |
Why?
|
| Sodium Bicarbonate | 1 | 2004 | 60 | 0.060 |
Why?
|
| Streptococcal Infections | 1 | 2009 | 619 | 0.060 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2004 | 53 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7449 | 0.060 |
Why?
|
| Biofilms | 1 | 2009 | 634 | 0.060 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2004 | 9 | 0.060 |
Why?
|
| Protein Binding | 2 | 2017 | 9376 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 1465 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2004 | 181 | 0.060 |
Why?
|
| Genitalia | 1 | 2024 | 113 | 0.060 |
Why?
|
| Anesthetics, Local | 1 | 2010 | 1005 | 0.060 |
Why?
|
| Growth | 1 | 2005 | 366 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2005 | 313 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 1797 | 0.050 |
Why?
|
| Clitoris | 1 | 2023 | 35 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2014 | 2589 | 0.050 |
Why?
|
| Telemedicine | 1 | 2021 | 3104 | 0.050 |
Why?
|
| Public Health | 1 | 2016 | 2693 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2013 | 20762 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 17647 | 0.050 |
Why?
|
| Enalapril | 1 | 2005 | 316 | 0.050 |
Why?
|
| Cost Control | 1 | 2005 | 627 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2022 | 1098 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 14766 | 0.050 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2022 | 19 | 0.050 |
Why?
|
| Rheumatic Heart Disease | 1 | 2004 | 164 | 0.050 |
Why?
|
| Acute Kidney Injury | 2 | 2005 | 1943 | 0.050 |
Why?
|
| Penis | 1 | 2023 | 213 | 0.050 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2022 | 44 | 0.050 |
Why?
|
| Analgesics | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3234 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2019 | 4737 | 0.050 |
Why?
|
| Rectal Neoplasms | 1 | 2011 | 1179 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3440 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7451 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2013 | 5103 | 0.050 |
Why?
|
| Antithyroid Agents | 2 | 2012 | 72 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2013 | 9182 | 0.050 |
Why?
|
| Colistin | 1 | 2022 | 46 | 0.050 |
Why?
|
| Logistic Models | 5 | 2021 | 13324 | 0.050 |
Why?
|
| Biopsy | 3 | 2021 | 6816 | 0.050 |
Why?
|
| Transfection | 1 | 2009 | 5767 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2009 | 1359 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5827 | 0.050 |
Why?
|
| Regenerative Medicine | 1 | 2024 | 311 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 4362 | 0.050 |
Why?
|
| Animals | 8 | 2024 | 169418 | 0.040 |
Why?
|
| Bordetella pertussis | 1 | 2020 | 45 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2279 | 0.040 |
Why?
|
| Hair | 1 | 2004 | 508 | 0.040 |
Why?
|
| Plasmodium falciparum | 1 | 2010 | 1746 | 0.040 |
Why?
|
| Stomach Diseases | 1 | 2002 | 134 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 1461 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3735 | 0.040 |
Why?
|
| Candida glabrata | 1 | 2020 | 38 | 0.040 |
Why?
|
| Risk Assessment | 7 | 2019 | 24311 | 0.040 |
Why?
|
| Seasons | 2 | 2018 | 1526 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2005 | 518 | 0.040 |
Why?
|
| Antioxidants | 1 | 2008 | 1678 | 0.040 |
Why?
|
| Adenoviruses, Human | 1 | 2022 | 257 | 0.040 |
Why?
|
| Chemokine CCL7 | 1 | 2019 | 30 | 0.040 |
Why?
|
| Chemokine CXCL6 | 1 | 2019 | 14 | 0.040 |
Why?
|
| Hypernatremia | 2 | 2011 | 78 | 0.040 |
Why?
|
| Chemokine CXCL5 | 1 | 2019 | 27 | 0.040 |
Why?
|
| Depsipeptides | 1 | 2020 | 96 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 2021 | 203 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2019 | 64 | 0.040 |
Why?
|
| Drug Therapy, Combination | 3 | 2019 | 6320 | 0.040 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2019 | 102 | 0.040 |
Why?
|
| Goats | 1 | 2019 | 166 | 0.040 |
Why?
|
| Mutation | 3 | 2020 | 30243 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 20231 | 0.040 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 284 | 0.040 |
Why?
|
| Program Development | 1 | 2005 | 1296 | 0.040 |
Why?
|
| Gliadin | 1 | 2019 | 80 | 0.040 |
Why?
|
| Azithromycin | 1 | 2020 | 200 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2014 | 4533 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4249 | 0.040 |
Why?
|
| Steroids | 1 | 2004 | 937 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2020 | 227 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 13065 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2021 | 865 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 296 | 0.040 |
Why?
|
| Glioma | 1 | 2013 | 3523 | 0.040 |
Why?
|
| Computational Biology | 1 | 2010 | 3546 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2023 | 699 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2024 | 663 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 1518 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2004 | 783 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 987 | 0.040 |
Why?
|
| Vena Cava, Inferior | 1 | 2021 | 463 | 0.040 |
Why?
|
| Vitamin D | 2 | 2021 | 3311 | 0.040 |
Why?
|
| Candidiasis | 1 | 2020 | 367 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2024 | 3635 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 2020 | 326 | 0.040 |
Why?
|
| Weight Loss | 1 | 2009 | 2710 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2020 | 3955 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 621 | 0.040 |
Why?
|
| Candida albicans | 1 | 2020 | 376 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 3463 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2022 | 590 | 0.040 |
Why?
|
| Maintenance | 1 | 2017 | 25 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13452 | 0.040 |
Why?
|
| Mentors | 1 | 2022 | 672 | 0.030 |
Why?
|
| Cholecalciferol | 1 | 2021 | 557 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2020 | 504 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 144 | 0.030 |
Why?
|
| Peritoneum | 1 | 2018 | 231 | 0.030 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2018 | 197 | 0.030 |
Why?
|
| Multigene Family | 1 | 2019 | 1081 | 0.030 |
Why?
|
| Spain | 1 | 2017 | 491 | 0.030 |
Why?
|
| Myocarditis | 1 | 2004 | 804 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2011 | 4340 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3543 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 212 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2015 | 2228 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2017 | 236 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8721 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 857 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 5096 | 0.030 |
Why?
|
| Gastroenteritis | 1 | 2017 | 236 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1640 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9425 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2021 | 1804 | 0.030 |
Why?
|
| Ecological and Environmental Phenomena | 1 | 2014 | 10 | 0.030 |
Why?
|
| Gastropoda | 1 | 2014 | 9 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18478 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2015 | 408 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 2010 | 916 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4780 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2018 | 908 | 0.030 |
Why?
|
| Cell Line | 3 | 2017 | 15609 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2024 | 1890 | 0.030 |
Why?
|
| Geologic Sediments | 1 | 2014 | 82 | 0.030 |
Why?
|
| Ecology | 1 | 2014 | 105 | 0.030 |
Why?
|
| Dobutamine | 1 | 2014 | 116 | 0.030 |
Why?
|
| Gynecology | 1 | 2020 | 532 | 0.030 |
Why?
|
| Acinetobacter Infections | 1 | 2014 | 73 | 0.030 |
Why?
|
| Homocystinuria | 1 | 2014 | 64 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 469 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2015 | 277 | 0.030 |
Why?
|
| Cell Size | 1 | 2015 | 626 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6400 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2015 | 298 | 0.030 |
Why?
|
| Nuclear Medicine | 1 | 2017 | 259 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 664 | 0.030 |
Why?
|
| Vitamins | 1 | 2021 | 1638 | 0.030 |
Why?
|
| Brain | 4 | 2021 | 27438 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2017 | 549 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2014 | 301 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2014 | 276 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 454 | 0.030 |
Why?
|
| Obstetrics | 1 | 2020 | 676 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2024 | 10494 | 0.030 |
Why?
|
| Ammonia | 1 | 2013 | 249 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 1855 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 6091 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2017 | 947 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1891 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1764 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2014 | 473 | 0.020 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2014 | 190 | 0.020 |
Why?
|
| Vacuoles | 1 | 2012 | 225 | 0.020 |
Why?
|
| Infant Formula | 1 | 2013 | 195 | 0.020 |
Why?
|
| Atrophy | 1 | 2017 | 1648 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 740 | 0.020 |
Why?
|
| Aged | 3 | 2021 | 171520 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2002 | 1926 | 0.020 |
Why?
|
| Energy Intake | 1 | 2019 | 2141 | 0.020 |
Why?
|
| Abdominal Pain | 2 | 2011 | 1070 | 0.020 |
Why?
|
| Carbimazole | 1 | 2011 | 4 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 1337 | 0.020 |
Why?
|
| Suppositories | 1 | 2010 | 16 | 0.020 |
Why?
|
| Critical Care | 1 | 2004 | 2717 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 2010 | 56 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 2010 | 63 | 0.020 |
Why?
|
| Maternal Age | 1 | 2013 | 809 | 0.020 |
Why?
|
| Survivors | 1 | 2021 | 2381 | 0.020 |
Why?
|
| Water | 1 | 2017 | 1421 | 0.020 |
Why?
|
| Feces | 1 | 2017 | 1515 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2013 | 823 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 2846 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 2010 | 141 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 524 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1172 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4586 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3816 | 0.020 |
Why?
|
| Sterilization | 1 | 2010 | 132 | 0.020 |
Why?
|
| Pentazocine | 1 | 2009 | 12 | 0.020 |
Why?
|
| Mefenamic Acid | 1 | 2009 | 5 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2010 | 100 | 0.020 |
Why?
|
| Pain Measurement | 2 | 2010 | 3577 | 0.020 |
Why?
|
| Echoencephalography | 1 | 2010 | 134 | 0.020 |
Why?
|
| Safety | 1 | 2014 | 1159 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2009 | 58 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2009 | 326 | 0.020 |
Why?
|
| Audiometry | 1 | 2010 | 253 | 0.020 |
Why?
|
| Pain Perception | 1 | 2010 | 198 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2010 | 518 | 0.020 |
Why?
|
| Algorithms | 3 | 2019 | 14158 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5904 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3445 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2010 | 255 | 0.020 |
Why?
|
| Artemisinins | 1 | 2010 | 218 | 0.020 |
Why?
|
| Calcium | 1 | 2021 | 5793 | 0.020 |
Why?
|
| Diazepam | 1 | 2009 | 215 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 299 | 0.020 |
Why?
|
| Middle Aged | 7 | 2019 | 223418 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 1885 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 8635 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 1464 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2009 | 305 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1053 | 0.020 |
Why?
|
| Industry | 1 | 2010 | 366 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2010 | 301 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 1575 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2016 | 2131 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 17149 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 781 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 934 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11138 | 0.020 |
Why?
|
| Dopamine | 1 | 2014 | 1616 | 0.020 |
Why?
|
| Schizosaccharomyces | 1 | 2009 | 237 | 0.020 |
Why?
|
| Tubulin | 1 | 2010 | 695 | 0.020 |
Why?
|
| Hemolysis | 1 | 2008 | 419 | 0.020 |
Why?
|
| Length of Stay | 1 | 2020 | 6521 | 0.020 |
Why?
|
| Endometrium | 1 | 2009 | 407 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 1503 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 12096 | 0.020 |
Why?
|
| Anesthetics, Intravenous | 1 | 2009 | 396 | 0.020 |
Why?
|
| Retina | 1 | 2016 | 2663 | 0.020 |
Why?
|
| Acetylglucosaminidase | 1 | 2005 | 66 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2014 | 1973 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2009 | 469 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 6309 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2010 | 2286 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 478 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1516 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2072 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 8611 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 659 | 0.010 |
Why?
|
| Partial Pressure | 1 | 2004 | 247 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2011 | 2656 | 0.010 |
Why?
|
| Registries | 1 | 2021 | 8373 | 0.010 |
Why?
|
| Serum | 1 | 2005 | 208 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2005 | 329 | 0.010 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 940 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 2004 | 113 | 0.010 |
Why?
|
| Antimalarials | 1 | 2010 | 910 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2009 | 9687 | 0.010 |
Why?
|
| Age of Onset | 1 | 2011 | 3342 | 0.010 |
Why?
|
| Folic Acid | 1 | 2010 | 1336 | 0.010 |
Why?
|
| Cranial Nerves | 1 | 2004 | 98 | 0.010 |
Why?
|
| Pneumonia | 1 | 2015 | 2162 | 0.010 |
Why?
|
| Demography | 1 | 2008 | 1643 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2005 | 681 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 36840 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 259 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2640 | 0.010 |
Why?
|
| Pericarditis | 1 | 2004 | 136 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 1274 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5808 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2012 | 4180 | 0.010 |
Why?
|
| Tachycardia | 1 | 2004 | 599 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 15460 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2009 | 894 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2019 | 13030 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 596 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2009 | 1188 | 0.010 |
Why?
|
| Educational Status | 1 | 2008 | 2519 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4120 | 0.010 |
Why?
|
| Contrast Media | 1 | 2013 | 5336 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2004 | 1152 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2014 | 5620 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10865 | 0.010 |
Why?
|
| Creatinine | 1 | 2005 | 1915 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10647 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 2056 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1629 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2004 | 872 | 0.010 |
Why?
|
| Electromyography | 1 | 2004 | 1399 | 0.010 |
Why?
|
| Poverty | 1 | 2010 | 2719 | 0.010 |
Why?
|
| Base Sequence | 1 | 2009 | 12428 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 2680 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3278 | 0.010 |
Why?
|
| Abdomen | 1 | 2004 | 1136 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5803 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5371 | 0.010 |
Why?
|
| Mice | 1 | 2024 | 82045 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3145 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 19041 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10601 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2010 | 6278 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2483 | 0.010 |
Why?
|
| Software | 1 | 2010 | 4463 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 1668 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7863 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2004 | 1414 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9505 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 12875 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 11206 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13589 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 18048 | 0.000 |
Why?
|
| United States | 1 | 2015 | 73121 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2002 | 9382 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21156 | 0.000 |
Why?
|